The effectiveness of citalopram for idiopathic chronic fatigue

Journal of Clinical Psychiatry

Volumn 64, Issue 8, 2003, Pages 927-935

  Hartz, Arthur J ^a   Bentler, Suzanne E ^a   Brake, Kathleen A ^a   Kelly, Michael W ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; PLACEBO;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; IDIOPATHIC CHRONIC FATIGUE; INSOMNIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RAND VITALITY INDEX; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEX DIFFERENCE; SEXUAL DYSFUNCTION; STATISTICAL ANALYSIS;

EID: 0042512491     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0811     Document Type: Article

References (44)

1. Wessely S, Chalder T, Hirsch S, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Pub Health 1997;87:1449-1455
2. Nelson E, Kirk J, McHugo G, et al. Chief complaint fatigue: a longitudinal study from the patient's perspective. Fam Pract Res J 1987;6:175-188
3. National Center for Health Statistics. The National Ambulatory Medical Care Survey: 1975 Summary. Hyattsville, Md: National Center for Health Statistics; 1978:22-26
4. David A, Pelosi A, McDonald E, et al. Tired, weak, or in need of rest: fatigue among general practice attenders. Br Med J 1990;301:1199-1202
5. Solberg LI. Lassitude: a primary care evaluation. JAMA 1984;251: 3272-3276
6. Bates D, Schmitt W, Lee J, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intem Med 1993; 153:2759-2765
7. Kroenke K, Wood DR, Mangelsdorff D, et al. Chronic fatigue in primary care: prevalence, patient characteristics, and outcome. JAMA 1988;260: 929-934
8. Sugarman JR, Berg AO. Evaluation of fatigue in a family practice. J Fam Pract 1984; 19:643-647
9. Cope H. Fatigue: a non-specific complaint? Int Rev Psychiatry 1992;4: 273-280
10. Cathebras PJ, Robbins JM, Kirmayer LJ. Fatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Intem Med 1992;7:276-286
11. Clark MR, Katon W, Russo J, et al. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study. Am J Med 1995; 98:187-195
12. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intem Med 1994;121:953-959
13. Lloyd A, Hickie I, Boughton R, et al. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990;153:522-528
14. Hartz AJ, Kuhn EM, Levine PH. Characteristics of fatigued persons associated with features of chronic fatigue syndrome. J Chronic Fatigue Syndrome 1998;4:71-97
15. Hartz AJ, Kuhn EM, Bentler SE, et al. Prognostic factors for persons with chronic fatigue. Arch Fam Med 1999;8:495-501
16. Hickie I, Lloyd A, Hadzi-Pavlovic D, et al. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med 1995;25:925-935
17. Whiting P, Bagnall AM, Sowden AJ, et al. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001;286:1360-1368
18. Straus SE. History of chronic fatigue syndrome. Rev Infect Dis 1991;13: S2-S7
19. Jones JF. Chronic Epstein-Barr virus infection. Ann Rev Med 1987;38: 195-209
20. Goodnick PJ, Sandoval R. Psychotropic treatment of chronic fatigue syndrome and related disorders. J Clin Psychiatry 1993;54:13-20
21. Behan PO, Hhaniffah BAG, Doogan DP, et al. A pilot study of sertraline for the treatment of chronic fatigue syndrome. Clin Infect Dis 1994;18:S111
22. Vercoulen JHMM, Swanink CMA, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347:858-861
23. Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 1998;172:485-490
24. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997;54:692-693
25. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996;155:293-295
26. Brook RH, Ware JE, Davies-Avery A, et al. Overview of adult health status measures fielded in Rand's health insurance study. Med Care 1979; 17:24-25
27. Valdini AF, Steinhardt S, Valicenti J, et al. A one-year follow-up of fatigued patients. J Fam Pract 1988;26:33-38
28. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33
29. Watson D, Clark LA, Weber K, et al. Testing a tripartite model, 2: exploring the symptom structure of anxiety and depression in student, adult, and patient samples. J Abnorm Psychol 1995;194:15-25
30. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-153
31. Barsky AJ, Cleary PD, Wyshak G, et al. A structural diagnostic interview for hypochondriasis: a proposed criterion standard. J Nerv Ment Dis 1992;180:20-27
32. Judge R, Plewes JM, Kumar V, et al. Changes in energy during treatment of depression: an analysis of fluoxetine in double-blind, placebo-controlled trials. J Clin Psychopharmacol 2000;20:666-672
33. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
34. SAS. Statistical Software V8. Cary, NC: SAS Institute, Inc; 1999
35. Tomkins GE, Jackson JL, O'Malley PG, et al. Treatment of chronic headache with antidepressants: a meta-analysis. Am J Med 2001;111:54-63
36. Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000;20: 603-610
37. d'Amato CC, Pizza V, Marmolo T, et al. Fluoxetine for migraine prophylaxis: a double-blind trial. Headache 1999;39:716-719
38. O'Malley, Balden E, Tomkins G, et al. Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intem Med 2000;15:659-666
39. Anderberg UM, Marteinsdottir I, von Knorring L. Citalopram in patients with fibromyalgia: a randomized, double-blind, placebo-controlled study. Eur J Pain 2000;4:27-35
40. Goldenberg D, Mayskiy M, Mossey C, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39:1852-1859
41. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996;61:285-290
42. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. JAMA 2000;342:1878-1886
43. Ioannidis JPA, Haidich A-B, Pappa M, et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001;286:821-830
44. Blondel-Hill E, Shafran SD. Treatment of the chronic fatigue syndrome: a review and practical guide. Drugs 1993;46:639-651